株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国における婦人科用医療機器市場の見通し

United States Gynecological Devices Market Outlook to 2023

発行 GlobalData 商品コード 307799
出版日 ページ情報 英文 68 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.95円で換算しております。
Back to Top
米国における婦人科用医療機器市場の見通し United States Gynecological Devices Market Outlook to 2023
出版日: 2017年05月01日 ページ情報: 英文 68 Pages
概要

当レポートでは、米国における婦人科用医療機器の売上および出荷量の実績と今後の予測、平均価格の推移を市場セグメント別に提供しています。また、各市場カテゴリーにおける企業シェアおよび流通シェアのデータ、主要企業のプロファイル、パイプライン製品、主な財務取引状況についての最新情報などをまとめています。

第1章 目次

第2章 イントロダクション

  • 当レポートについて
  • 婦人科用医療機器市場の分類
  • 当レポートの市場範囲と定義

第3章 婦人科用医療機器の米国市場

  • 婦人科用医療機器の米国市場:収益実績($m)
  • 婦人科用医療機器の米国市場:収益予測($m)
    • 女性用不妊手術装置のセグメント別収益実績($m)
    • 子宮内膜アブレーション装置のセグメント別収益実績($m)
    • 子宮筋腫塞栓物質のセグメント別収益実績($m)
    • 女性用不妊手術装置のセグメント別収益予測($m)
    • 子宮内膜アブレーション装置のセグメント別収益予測($m)
    • 子宮筋腫塞栓物質のセグメント別収益予測($m)
  • 婦人科用医療機器の米国市場:出荷量の実績
  • 婦人科用医療機器の米国市場:出荷量の予測
    • 女性用不妊手術装置の出荷量実績
    • 子宮内膜アブレーション装置の出荷量実績
    • 子宮筋腫塞栓物質の出荷量実績
    • 女性用不妊手術装置の出荷量予測
    • 子宮内膜アブレーション装置の出荷量予測
    • 子宮筋腫塞栓物質の出荷量予測
  • 婦人科用医療機器の米国市場:平均販売価格の推移
  • 婦人科用医療機器の米国市場:収益ベースの流通シェア($m)
  • 婦人科用医療機器の米国市場:収益ベースの企業シェア($m)

第4章 米国の婦人科用医療機器市場における主要企業の概要

  • Conceptus, Inc.
  • Hologic, Inc.
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • CooperSurgical, Inc.
  • Merit Medical Systems, Inc.
  • Johnson & Johnson
  • Utah Medical Products, Inc.
  • BSD Medical Corporation

第5章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDMECC2126DB

GlobalData's new report, "United States Gynecological Devices Market Outlook to 2023", provides key market data on the United States Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Female Sterilization Devices, Endometrial Ablation Devices, Uterine Fibroid Ablation Devices and Uterine Fibroid Embolization Agents.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Gynecological Devices market segments - Female Sterilization Devices, Endometrial Ablation Devices, Uterine Fibroid Ablation Devices and Uterine Fibroid Embolization Agents.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the United States Gynecological Devices market.
  • Key players covered include Hologic Inc, CooperSurgical Inc, Bayer AG and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 What Is This Report About? 6
  • 2.2 Gynecological Devices Market Segmentation 6
  • 2.3 Definitions of Markets Covered in the Report 7

3 Gynecological Devices Market, United States 9

  • 3.1 Gynecological Devices Market, United States, Revenue ($m), 2009-2016 9
  • 3.2 Gynecological Devices Market, United States, Revenue ($m), 2016-2023 11
    • 3.2.1 Endometrial Ablation Devices Market, United States, Revenue ($m), by Segment, 2009-2016 13
    • 3.2.2 Female Sterilization Devices Market, United States, Revenue ($m), by Segment, 2009-2016 15
    • 3.2.3 Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), by Segment, 2009-2016 17
    • 3.2.4 Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), by Segment, 2009-2016 18
    • 3.2.5 Endometrial Ablation Devices Market, United States, Revenue ($m), by Segment, 2016-2023 20
    • 3.2.6 Female Sterilization Devices Market, United States, Revenue ($m), by Segment, 2016-2023 22
    • 3.2.7 Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), by Segment, 2016-2023 24
    • 3.2.8 Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), by Segment, 2016-2023 25
  • 3.3 Gynecological Devices Market, United States, Volume (Units), 2009-2016 27
  • 3.4 Gynecological Devices Market, United States, Volume (Units), 2016-2023 29
    • 3.4.1 Endometrial Ablation Devices Market, United States, Volume (Units), by Segment, 2009-2016 31
    • 3.4.2 Female Sterilization Devices Market, United States, Volume (Units), by Segment, 2009-2016 33
    • 3.4.3 Uterine Fibroid Ablation Devices Market, United States, Volume (Units), by Segment, 2009-2016 35
    • 3.4.4 Uterine Fibroid Embolization Agents Market, United States, Volume (Units), by Segment, 2009-2016 36
    • 3.4.5 Endometrial Ablation Devices Market, United States, Volume (Units), by Segment, 2016-2023 38
    • 3.4.6 Female Sterilization Devices Market, United States, Volume (Units), by Segment, 2016-2023 40
    • 3.4.7 Uterine Fibroid Ablation Devices Market, United States, Volume (Units), by Segment, 2016-2023 42
    • 3.4.8 Uterine Fibroid Embolization Agents Market, United States, Volume (Units), by Segment, 2016-2023 43
  • 3.5 Gynecological Devices Market, United States, Average Price ($), 2009-2023 45
  • 3.6 Gynecological Devices Market, United States, Distribution Share by Revenue ($m), 2016 47
  • 3.7 Gynecological Devices Market, United States, Company Share by Revenue ($m), 2016 48

4 Overview of Key Companies in United States, Gynecological Devices Market 50

  • 4.1 Bayer AG 50
    • 4.1.1 Company Overview 50
  • 4.2 Utah Medical Products, Inc. 50
    • 4.2.1 Company Overview 50
  • 4.3 Hologic Inc 50
    • 4.3.1 Company Overview 50
  • 4.4 Ethicon Inc 51
    • 4.4.1 Company Overview 51
  • 4.5 Merit Medical Systems, Inc. 51
    • 4.5.1 Company Overview 51
  • 4.6 Boston Scientific Corp 51
    • 4.6.1 Company Overview 51
  • 4.7 Cook Group Inc 51
    • 4.7.1 Company Overview 51
  • 4.8 CooperSurgical Inc 52
    • 4.8.1 Company Overview 52

5 Gynecological Devices Market Pipeline Products 53

6 Financial Deals Landscape 54

  • 6.1 Acquisition 54
    • 6.1.1 Hologic Acquires Cynosure in Tender Offer 54

7 Recent Developments 56

  • 7.1 Corporate Communications 56
    • 7.1.1 Nov 15, 2016: Cynosure Health Welcomes Three New Board Members 56
    • 7.1.2 Nov 01, 2016: Cynosure Promotes Doug Delaney to Chief Commercial Officer 56
    • 7.1.3 Sep 13, 2016: Cynosure to Name Stephen J. Webber as New Chief Financial Officer 57
    • 7.1.4 May 25, 2016: Cynosure Announces Planned Retirement of Timothy W. Baker as President, Chief Financial Officer and Chief Operating Officer 57
  • 7.2 Financial Announcements 58
    • 7.2.1 Feb 07, 2017: Cynosure Achieves Record Quarterly Revenue of $122.1 Million in the Fourth Quarter of 2016, Up 19 Percent Year-over-Year 58
    • 7.2.2 Oct 25, 2016: Cynosure Announces Record Third-Quarter Revenues; Revenues Increase 36 Percent from Prior Year to $106.4 Million 59
    • 7.2.3 Jul 26, 2016: Cynosure Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter of 2016 60

8 Appendix 62

  • 8.1 Research Methodology 63
    • 8.1.1 Coverage 63
    • 8.1.2 Secondary Research 63
    • 8.1.3 Primary Research 64
    • 8.1.4 Market Modeling and Forecasting 65
    • 8.1.5 Company Share Analysis 66
    • 8.1.6 Distribution Share Analysis 67
    • 8.1.7 Benchmarking 67
  • 8.2 GlobalData Consulting 67
  • 8.3 Contact Us 68
  • 8.4 Disclaimer 68

List of Tables

1.1 List of Tables

  • Table 1: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 10
  • Table 2: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 12
  • Table 3: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 14
  • Table 4: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 16
  • Table 5: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 17
  • Table 6: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 19
  • Table 7: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 21
  • Table 8: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 23
  • Table 9: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 24
  • Table 10: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 26
  • Table 11: Gynecological Devices Market, United States, Volume (Units), Historic, 2009-2016 28
  • Table 12: Gynecological Devices Market, United States, Volume (Units), Forecast, 2016-2023 30
  • Table 13: Endometrial Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016 32
  • Table 14: Female Sterilization Devices Market, United States, Volume (Units), Historic, 2009-2016 34
  • Table 15: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016 35
  • Table 16: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Historic, 2009-2016 37
  • Table 17: Endometrial Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023 39
  • Table 18: Female Sterilization Devices Market, United States, Volume (Units), Forecast, 2016-2023 41
  • Table 19: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023 42
  • Table 20: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Forecast, 2016-2023 44
  • Table 21: Gynecological Devices Market, United States, Average Price ($) Historic, 2009-2016 45
  • Table 22: Gynecological Devices Market, United States, Average Price ($), Forecast, 2016-2023 46
  • Table 23: Gynecological Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2016 47
  • Table 24: Gynecological Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016 49
  • Table 25: Gynecological Devices Market Pipeline Products 53
  • Table 26: Hologic Acquires Cynosure in Tender Offer 54
  • Table 27: Total Number of Primary Research Participants, Diagnostic Imaging Equipment Market, by Country 65

List of Figures

1.2 List of Figures

  • Figure 1: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 9
  • Figure 2: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 11
  • Figure 3: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 13
  • Figure 4: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 15
  • Figure 5: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 17
  • Figure 6: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 18
  • Figure 7: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 20
  • Figure 8: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 22
  • Figure 9: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 24
  • Figure 10: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 25
  • Figure 11: Gynecological Devices Market, United States, Volume (Units), Historic, 2009-2016 27
  • Figure 12: Gynecological Devices Market, United States, Volume (Units), Forecast, 2016-2023 29
  • Figure 13: Endometrial Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016 31
  • Figure 14: Female Sterilization Devices Market, United States, Volume (Units), Historic, 2009-2016 33
  • Figure 15: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016 35
  • Figure 16: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Historic, 2009-2016 36
  • Figure 17: Endometrial Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023 38
  • Figure 18: Female Sterilization Devices Market, United States, Volume (Units), Forecast, 2016-2023 40
  • Figure 19: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023 42
  • Figure 20: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Forecast, 2016-2023 43
  • Figure 21: Gynecological Devices Market, United States, Company Share (%) 2016 48
Back to Top